ARCHIVES

ODAC Member Critical Of Amgen For Price Incentives.

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | March 21, 2008

Download PDF Visit The Full Archive

Related Articles

FDA Advisory Committee To Consider NDAs On Novantrone, HD MTX

November 27, 1987

Case Study: The Post-Surgical Treatment Of A Child With Medulloblastoma At The Burzynski Clinic

September 25, 1998

Blayney Elected ASCO President For 2009.

March 7, 2008

Clinical Instigator Object To HEW Proposal On Compensation Notification In Consent Forms

December 15, 1978

Professional Societies: ONS To Study Trends In Health Economics Affecting Nursing

October 4, 1996

Also C-Change new name for National Dialogue on Cancer.

January 16, 2004